Evaluation of Fatigue in U.S. Patients with Primary Biliary Cirrhosis
- 1 May 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 100 (5), 1104-1109
- https://doi.org/10.1111/j.1572-0241.2005.41315.x
Abstract
Fatigue, which may have a significant impact on quality of life, is the most common reported symptom in primary biliary cirrhosis (PBC). Multiple instruments to quantify fatigue and quality of life in liver disease have been validated, but have not been broadly applied to U.S. PBC patients. This study examines the extent of fatigue and its effect on quality of life in U.S. PBC patients. Seventy patients with PBC were administered two validated questionnaires about quality of life (the Mayo version of the NIDDK-QA) and fatigue (the Fisk Fatigue Impact Score) and a proposed physical measure of fatigue in PBC (the grip strength test) on the day of routine physician visit. Nonparametric methods were employed. The fatigue and quality of life domain scores (physical functioning, liver symptoms, health satisfaction, Karnofsky index) discriminated between patients with and without self-reported fatigue (p < 0.05), as opposed to the grip strength results. Fatigue and quality of life domains correlated strongly with each other (r between 0.33 and 0.74, p</= 0.006) and not with the grip strength results. Neither quality of life nor fatigue scores correlated with age. The correlation between fatigue and quality of life scores suggests fatigue has an impact on quality of life in U.S. primary biliary cirrhosis patients. However, our fatigue scores suggest U.S. PBC patients have less fatigue than non-U.S. PBC patients. The grip strength is an insensitive measure of fatigue in U.S. PBC patients.Keywords
This publication has 27 references indexed in Scilit:
- The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosisHepatology, 2000
- Management of primary biliary cirrhosisHepatology, 2000
- Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progressionHepatology, 1999
- Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosisHepatology, 1999
- Primary Biliary CirrhosisNew England Journal of Medicine, 1996
- Time course of histological progression in primary biliary cirrhosisHepatology, 1996
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- The demography of primary biliary cirrhosis in ontario, canadaHepatology, 1990
- Diminished survival in asymptomatic primary biliary cirrhosisGastroenterology, 1990